TTK Inhibitors as a Targeted Therapy for CTNNB1 ( β -catenin) Mutant Cancers
Year: 2017
Type: article
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
Funder: European Commission
OpenAlex ID: W2740081124
